Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Peoples Bancorp
PEBO
$1.5B
| $636K | ﹤0.01% |
18,338
+9,051
| +97% | +$296K |
|
|
CHK
4027
DELISTED
Chesapeake Energy Corporation
CHK
| $636K | ﹤0.01% |
3,856
+1,671
| +76% | +$336K |
|
4028
Viking Therapeutics
VKTX
$3.91B
| $635K | ﹤0.01% |
79,193
+45,173
| +133% | +$329K |
|
|
CCRN
4029
DELISTED
Cross Country Healthcare
CCRN
| $633K | ﹤0.01% |
54,541
+17,886
| +49% | +$202K |
|
4030
CALL
Assured Guaranty
AGO
$3.66B
| $632K | ﹤0.01% |
12,900
+4,800
| +59% | +$230K |
|
4031
CALL
Banc of California
BANC
$3.07B
| $632K | ﹤0.01% |
+36,800
| New | +$556K |
|
4032
Palomar
PLMR
$3.55B
| $632K | ﹤0.01% |
12,524
+9,625
| +332% | +$451K |
|
|
CAI
4033
DELISTED
CAI International, Inc.
CAI
| $632K | ﹤0.01% |
21,799
+8,110
| +59% | +$197K |
|
4034
UNIFI
UFI
$123M
| $631K | ﹤0.01% |
24,970
+7,384
| +42% | +$178K |
|
4035
Revolve Group
RVLV
$1.81B
| $630K | ﹤0.01% |
34,301
+33,901
| +8,475% | +$642K |
|
4036
PUT
Helen of Troy
HELE
$689M
| $629K | ﹤0.01% |
3,500
+2,900
| +483% | +$465K |
|
4037
Motorcar Parts of America
MPAA
$263M
| $628K | ﹤0.01% |
28,490
+9,253
| +48% | +$179K |
|
4038
CALL
ProShares Short VIX Short-Term Futures ETF
SVXY
$205M
| $626K | ﹤0.01% |
19,200
-17,400
| -48% | -$518K |
|
4039
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.64B
| $625K | ﹤0.01% |
+16,150
| New | +$625K |
|
4040
Tucows
TCX
$157M
| $624K | ﹤0.01% |
10,103
+1,382
| +16% | +$78.8K |
|
|
SPPI
4041
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $622K | ﹤0.01% |
170,865
-70,846
| -29% | -$572K |
|
|
APTS
4042
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $622K | ﹤0.01% |
46,643
+24,110
| +107% | +$333K |
|
4043
Radware
RDWR
$1.2B
| $619K | ﹤0.01% |
24,022
+1,758
| +8% | +$41.6K |
|
4044
CALL
Cheesecake Factory
CAKE
$5.23B
| $618K | ﹤0.01% |
15,900
-13,500
| -46% | -$557K |
|
4045
PUT
Itaú Unibanco
ITUB
$90.5B
| $618K | ﹤0.01% |
92,836
| – | – |
|
4046
PUT
United Parks & Resorts
PRKS
$2.17B
| $618K | ﹤0.01% |
19,500
+14,100
| +261% | +$407K |
|
|
FLIC
4047
DELISTED
First of Long Island Corp
FLIC
| $617K | ﹤0.01% |
24,575
+11,605
| +89% | +$277K |
|
|
HUD
4048
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $617K | ﹤0.01% |
40,291
+17,782
| +79% | +$232K |
|
4049
PUT
Direxion Daily Energy Bull 2X ETF
ERX
$217M
| $616K | ﹤0.01% |
3,520
+1,410
| +67% | +$217K |
|
4050
CALL
Alerian MLP ETF
AMLP
$12.8B
| $615K | ﹤0.01% |
14,460
-33,840
| -70% | -$1.42M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.